Quikhale FB 200 Powder for Inhalation
By Quikhale FB
Rx
30mdi Capsule in a Packet

Composition
Formoterol(6mcg) + Budesonide(200mcg)

Manufacturer - Intas Pharmaceuticals Ltd
Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Expires on or after
May, 2026
About Quikhale FB 200 Powder for Inhalation
Quikhale FB 200 Powder for Inhalation is a powerful combination inhaler that is specially designed to ease the chronic symptoms of asthma and Chronic Obstructive Pulmonary Disease (COPD). This innovative inhaler contains two important medicines, Budesonide and Formoterol, which work together to alleviate inflammation in the airways and relax the muscles, thus making it easier for patients to breathe.
Using Quikhale FB 200 Powder for Inhalation as prescribed by your doctor is crucial for its effectiveness. While some effects of the medicine may be noticed within a few days, the full benefits may take a few weeks to be realized. It is essential to use this inhaler regularly, even if you are not experiencing any symptoms, to ensure that it is working effectively to manage your condition. It is important to note that Quikhale FB 200 Powder for Inhalation should not be used for sudden shortness of breath; instead, a rescue inhaler should be used in such situations.
As with any medication, there may be some side effects associated with Quikhale FB 200 Powder for Inhalation. Common side effects include headache, nausea, stomach discomfort, and respiratory tract infections. It is advised not to discontinue the medication if you experience these side effects but to consult your doctor. Simple steps like rinsing your mouth and throat with water or brushing your teeth after inhalation can help minimize these side effects.
Before starting Quikhale FB 200 Powder for Inhalation, it is vital to inform your doctor about any existing kidney or liver diseases, as well as if you are pregnant, planning for pregnancy, or breastfeeding. This will help your doctor prescribe the most suitable dosage for you, ensuring your safety and effective treatment.
Quikhale FB 200 Powder for Inhalation is suitable for adults and children aged 6 years and above for the regular treatment of asthma and moderate to severe COPD with frequent symptoms and exacerbations. Regular monitoring and specific respiratory tests may be recommended by your doctor to assess the severity of your respiratory issues and lung function.
It is important to note that Quikhale FB 200 Powder for Inhalation is not recommended for individuals with allergies to its ingredients or during pregnancy or breastfeeding unless absolutely necessary. Additional precautions should be taken if you have certain health conditions like heart problems, high blood pressure, diabetes, immune disorders, or infections. Children under the age of 6 should not use this medication.
In conclusion, Quikhale FB 200 Powder for Inhalation is a reliable and effective treatment option for managing chronic respiratory conditions like asthma and COPD. Adhering to your doctor's instructions, being aware of possible side effects, and informing your healthcare provider about any preexisting conditions are key steps towards successful treatment with this inhaler.
Benefits
Quikhale FB 200 Powder for Inhalation offer a range of benefits for individuals dealing with chronic obstructive pulmonary disease (COPD) and asthma. In the treatment of COPD, this medication helps to keep the airways in the lungs open by relaxing the muscles, making it easier for air to flow in and out. This leads to relief from symptoms like chest tightness, shortness of breath, wheezing, and coughing. By easing these symptoms, Quikhale FB 200 Powder for Inhalation enable individuals to engage in their daily activities more comfortably. The effects of this medication are both safe and effective, typically kicking in within minutes and lasting for several hours, enhancing the quality of life for those with COPD. It is important to adhere to your doctor's advice and not discontinue usage without consultation.
Moreover, Quikhale FB 200 Powder for Inhalation are beneficial in the treatment and prevention of asthma. By taking this medication before exercise or exposure to potential triggers such as house dust, pollen, pets, or cigarette smoke, individuals can reduce the likelihood of an asthma attack. This proactive approach allows individuals to engage in physical activity without the fear of experiencing symptoms like wheezing, coughing, or shortness of breath. With Quikhale FB 200 Powder for Inhalation, individuals can lead a more active and unrestricted lifestyle, free from the constraints imposed by asthma triggers.
Quikhale FB 200 Powder for Inhalation 30's combines two effective drugs, Budesonide and Formoterol, to address asthma and COPD symptoms. Budesonide, a corticosteroid, works by reducing inflammation and irritation in the nasal lining, alleviating symptoms such as sneezing, runny or blocked nose, and sinus discomfort. On the other hand, Formoterol, a bronchodilator, relaxes muscles and widens the airways in the lungs, making breathing easier for individuals with respiratory conditions. This combination of drugs in Quikhale FB 200 Powder for Inhalation offers a comprehensive solution to manage and alleviate the symptoms of asthma and COPD, enhancing the overall well-being of individuals facing these respiratory challenges.
How to use the Quikhale FB 200 Powder for Inhalation
To properly use Quikhale FB 200 Powder for Inhalation, follow the instructions provided by your doctor. If you are using the inhaler/transhaler/turbuhaler, start by shaking it well and checking the label for directions. Hold the device with the mouthpiece down, place it between your teeth, and seal your lips around it. Press down the inhaler to release the medication, breathe in slowly, and hold your breath for 5 to 10 seconds before exhaling. Repeat this process until you have taken the number of puffs prescribed by your doctor. Remember to rinse your mouth with water and spit it out after each use to prevent fungal infections in the mouth and throat.
For rotacaps/transcaps/instacaps/redicaps, place the capsule at the base of the corresponding inhaler and twist the mouthpiece until you hear a click sound. Breathe in deeply through the mouthpiece, holding your breath for 10 seconds. It is important not to swallow the capsule as it is meant for inhalation only.
If you are using respules/smartules, first check the label for instructions. Twist the top of the respule/smartule, squeeze out all the liquid into the nebulizer, and use immediately after opening.
Remember to use Pulmosmart 200 Capsule exactly as directed by your doctor. This medication is for inhalation only, so be sure to carefully follow the dosing instructions provided. Your doctor will determine the right dose and duration based on factors such as your age, body weight, and the severity of your condition. Always consult your healthcare provider if you have any questions or concerns about using Quikhale FB 200 Powder for Inhalation.
Uses of Quikhale FB 200 Powder for Inhalation
The Quikhale FB 200 Powder for Inhalation are used for treating and preventing Chronic obstructive pulmonary disease (COPD) as well as Asthma. They are effective in managing asthma and moderate to severe COPD.
What conditions Quikhale FB 200 Powder for Inhalation treats?
Quikhale FB 200 Powder for Inhalation is designed to assist individuals with asthma and chronic obstructive pulmonary disease (COPD). Asthma is a chronic respiratory condition that causes airways to narrow, swell, and produce excess mucus, resulting in symptoms like wheezing, shortness of breath, chest tightness, and coughing, especially at night. Mild persistent asthma may occur more than twice a week and up to four nights a month, while severe persistent asthma can lead to daily symptoms. COPD comprises lung diseases like emphysema and chronic bronchitis, often caused by smoking or long-term exposure to fumes and chemicals, leading to symptoms such as chronic cough, shortness of breath, and wheezing.
Should you consult a doctor?
Seek medical attention immediately if you experience any of the following symptoms while using Quikhale FB 200 Powder for Inhalation: seizures, uncontrolled fits, unexplained changes in blood sugar levels associated with diabetes, or worsening symptoms of thyroid problems. Additionally, consult your doctor if you develop any signs of pheochromocytoma (an adrenal gland tumor), osteoporosis (a bone disease), or immune system disorders. It is crucial to seek medical advice if you notice any changes in your vision, such as increased pressure inside the eyes (glaucoma) or cloudy lens (cataracts). Furthermore, if you suspect you have been exposed to viral, bacterial, fungal, or parasitic infections, or if you have been in contact with individuals infected with measles or chicken pox, inform your healthcare provider. Lastly, if you have decreased potassium levels, untreated aneurysm (bulge in a blood vessel), or any other concerning symptoms, seek prompt medical attention.
Side effects of Quikhale FB 200 Powder for Inhalation
When taking Quikhale FB 200 Powder for Inhalation, you may experience some side effects, although most of them usually do not need medical attention and can resolve as your body gets used to the medication. Some common side effects you may encounter include nausea, vomiting, headache, stomach discomfort, cough, and inflammation of the throat and nasal passages known as nasopharyngitis. Other potential side effects include upper respiratory tract infections, sinus inflammation, fungal infection of the mouth and throat, tremors, palpitations, voice changes, back pain, and oral fungal infections. In some cases, you may also experience increased heart rate, blurred vision, muscle cramps, difficulty sleeping, rhinitis, ear infections, and gastrointestinal issues such as nausea, vomiting, and stomach pain. It is essential to consult your healthcare provider if any of these side effects persist or if you have concerns about them. Additionally, seek medical attention if you encounter more severe side effects such as depression, changes in behavior, chest pain, difficulty breathing, signs of pneumonia or other lung diseases, or serious allergic reactions like rashes, swelling, and breathing difficulties. Your doctor can provide guidance and support in managing any side effects to ensure your well-being while taking Quikhale FB 200 Powder for Inhalation.
Safety advice

liver
The Quikhale FB 200 Powder for Inhalation do not have any known interactions with the liver. This means that there have been no established negative effects or warnings specifically related to liver issues when using this medication. It is still important to take caution and monitor any changes in your liver health while using Quikhale FB 200 Powder for Inhalation. As always, consult with your doctor for proper guidance before using Quikhale FB 200 Powder for Inhalation.

kidney
No interaction found between Quikhale FB 200 Powder for Inhalation and kidney issues. Consult with your doctor for proper guidance before using.

alcohol
It is unsafe to drink alcohol while taking Quikhale FB 200 Powder for Inhalation. Avoid alcohol consumption while using this medication.

driving
When using Quikhale FB 200 Powder for Inhalation, no interactions have been found concerning driving. It's important to remain cautious and attentive while driving.

pregnancy
Quikhale FB 200 Powder for Inhalation is considered safe in pregnancy, with animal studies showing minimal risks to the baby. Limited human studies are available.

breastfeeding
During breastfeeding, it is believed that Quikhale FB 200 Powder for Inhalation are safe to use according to limited human data. There is no significant risk to the baby reported.
Age above 75(Geriatrics)
Quikhale FB 200 Powder for Inhalation CAPSULE is used with caution in elderly people with heart diseases. Consult doctor before using PULMOSMART 200 CAPSULE.
Age below 6 months(Pediatrics)
PULMOSMART 200 CAPSULE is not recommended to use in children below 6 years of age due to lack of safety data. Consult your doctor before receiving PULMOSMART 200 CAPSULE. PULMOSMART 200 CAPSULE should be used with caution in children above 6 years of age. Your doctor will monitor the height and growth of children while using PULMOSMART 200 CAPSULE. Consult your doctor for advice.
Consumption warning before consuming Quikhale FB 200 Powder for Inhalation
Before using Quikhale FB 200 Powder for Inhalation 30's, it is crucial to consider several factors. If you have allergies to lactose or any other components, inform your doctor. For pregnant or breastfeeding individuals, consulting a doctor before use is recommended. This medication is not suitable for children below 6 years of age. Pay attention to any worsening asthma symptoms like frequent night awakenings, morning chest tightness, or prolonged symptoms, which may indicate the need for different treatment. Regular monitoring of potassium levels is advised due to potential potassium level fluctuations. Be cautious around individuals with infections, as Quikhale FB 200 Powder for Inhalation 30's may lower immunity. Inform your doctor if you have specific conditions such as high blood pressure, diabetes, or immune system disorders before starting this medication.
What if you forgot to take Quikhale FB 200 Powder for Inhalation?
If you forget to take a dose of Quikhale FB 200 Powder for Inhalation, try to take it as soon as you remember. But if it's close to the time for your next dose, just skip the missed one and stick to your usual dosing schedule. Avoid taking a double dose to make up for the missed one.
What happens if you take overdose of Quikhale FB 200 Powder for Inhalation?
If too much Quikhale FB 200 Powder for Inhalation is taken accidentally, urgent medical attention is needed. Signs of an overdose include seizures, chest pain, fluctuations in blood pressure, rapid heartbeat, anxiety, headaches, shakiness, fluttering sensations in the chest, muscle aches, nausea, dizziness, sleeping problems, metabolic acidosis, elevated blood sugar, and lower levels of potassium. In severe cases, overdose can lead to cardiac arrest and potentially fatal outcomes. Immediate consultation with a healthcare professional or a visit to the nearest hospital is crucial in case of a suspected overdose situation.
Related lab tests
When looking into related lab tests for Quikhale FB 200 Powder for Inhalation, two key tests to consider are Absolute Eosinophil Count and Complete Blood Count. An Absolute Eosinophil Count measures the number of eosinophils, a type of white blood cell, in the blood. Eosinophils play a role in allergic reactions and certain types of infections. This test helps in diagnosing conditions such as asthma, allergies, and parasitic infections. A Complete Blood Count, on the other hand, provides valuable information on various components of blood, including red blood cells, white blood cells, and platelets. It can help identify anemia, infections, and other blood disorders. Ensuring these tests are conducted can provide important insights into the respiratory health of individuals using Quikhale FB 200 Powder for Inhalation.
Additional Information
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹399
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024